Literature DB >> 14513274

[Adrenocortical tumours].

W Saeger1.   

Abstract

Adrenocortical tumours have to be differentiated from cortical hyperplasias, medullary tumours and extra-adrenal tumours or metastases. These diagnoses are mostly possible using routine paraffin sections. In some cases, immunostaining for differing cortical and medullary tumours and metastases are necessary. Adrenal hyperplasias can be congenital or acquired. They are diffuse, micronodular or macronodular and may be inactive or induce a cortical hyperfunction. Very rarely, macronodular hyperplasias may transform into autonomous adenomas. Primary, pigmented adrenocortical disease is a rare, special type of primary adrenal Cushing's syndrome, showing many small tumours with pleomorphic cells and an atrophic surrounding cortical tissue. Adrenal adenomas are mostly unilateral and solitary tumours weighing less than 50 g. Adrenal cortical carcinomas are mostly larger. Like the adenomas, they may be inactive and may induce a hypercortisolism, a hyperandrogenism or (very rarely in carcinomas) a hyperaldosteronism. Differentiating cortical adenomas and carcinomas is difficult in some cases but is possible using a diagnostic algorithm. Myelolipomas are benign, inactive tumours composed of mature fat cells and bone marrow cells. They have to be differentiated from adenomas with myelolipomatous metaplasia. Further, rare primary cortical tumours are mentioned.

Entities:  

Mesh:

Year:  2003        PMID: 14513274     DOI: 10.1007/s00292-003-0621-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  21 in total

1.  bcl-2 expression in normal adrenal glands and in adrenal neoplasms.

Authors:  F Fogt; A O Vortmeyer; C Poremba; M Minda; C A Harris; J E Tomaszewski
Journal:  Mod Pathol       Date:  1998-08       Impact factor: 7.842

2.  Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data.

Authors:  A J Hough; J W Hollifield; D L Page; W H Hartmann
Journal:  Am J Clin Pathol       Date:  1979-09       Impact factor: 2.493

3.  Expression of HER-2/neu receptor protein in adrenal tumors.

Authors:  W Saeger; M Fassnacht; M Reincke; B Allolio
Journal:  Pathol Res Pract       Date:  2002       Impact factor: 3.250

4.  Myelolipoma arising from ectopic adrenal cortex: case report and review of the literature.

Authors:  S H Stein; F Latour; S S Frost
Journal:  Am J Gastroenterol       Date:  1986-10       Impact factor: 10.864

Review 5.  Cushing's syndrome and the nodular adrenal gland.

Authors:  M H Samuels; D L Loriaux
Journal:  Endocrinol Metab Clin North Am       Date:  1994-09       Impact factor: 4.741

6.  Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.

Authors:  H Nakazumi; H Sasano; K Iino; Y Ohashi; S Orikasa
Journal:  Mod Pathol       Date:  1998-12       Impact factor: 7.842

7.  The alpha subunit of inhibin in adrenal cortical neoplasia.

Authors:  T J Pelkey; H F Frierson; S E Mills; M H Stoler
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

8.  Hyperplastic and Tumorous Lesions of the Adrenals in an Unselected Autopsy Series.

Authors:  Wolfgang Saeger; Karin Reinhard; Christina Reinhard
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

9.  Fat-Cell Metaplasia in the Adrenal Cortex: Incidence, Structure, and Correlation to Basic Diseases in a Postmortem Series.

Authors:  Wolfgang Saeger; Karin Reinhard
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

Review 10.  Pathology of adrenal neoplasms.

Authors:  W Saeger
Journal:  Minerva Endocrinol       Date:  1995-03       Impact factor: 2.184

View more
  2 in total

Review 1.  [Adrenal gland tumors].

Authors:  H S Willenberg; D Zschucke; S R Bornstein
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

2.  Simultaneous ectopic adrenocorticotropic hormone syndrome and adrenal metastasis of a medullary thyroid carcinoma causing paraneoplastic Cushing's syndrome.

Authors:  Michael Sand; Samuel Uecker; Falk G Bechara; Marcos Gelos; Daniel Sand; Till H Wiese; Benno Mann
Journal:  Int Semin Surg Oncol       Date:  2007-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.